Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tocilizumab in the Treatment of Refractory Granulomatous Lobular Mastitis: A Two-Center, Single-Arm Clinical Trial

NCT07595900 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.

NCT NCT07595900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tocilizumab in the Treatment of Refractory Granulomatous Lobular Mastitis: A Two-Center, Single-Arm Clinical Trial
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
October 30, 2028
Enrollment
31 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

granulomatous lobular mastitis, granulomatous mastitis